A story of pioneering and trust
Discover the milestones that transformed Cardios into a reference in cardiological diagnostics in Brazil and worldwide.
Excellence in diagnosis, trust in every heartbeat
Since 1977, Cardios has been developing cardiological diagnostic solutions that combine technology, reliability, and medical support.
Our Mission
Innovate patient monitoring by offering solutions that combine technological precision, reliability, and support to save lives.
Our Vision
To be a global reference in data collection and analysis technology for the diagnosis and prevention of heart diseases.
Our Values
Ethics, quality, responsibility, respect for the customer, and a continuous commitment to life.
Check out our Timeline
With over four decades of experience, we deliver solutions that combine engineering excellence and medical trust.
1987
Cardios revolutionizes the Holter market by launching Dynamis, the world's first recorder to operate with just two batteries. This innovation brought more practicality and efficiency to cardiovascular diagnosis, becoming a landmark for the company.
1995
In partnership with the German leader IEM, Cardios launches in Brazil the Dyna-MAPA, one of the most advanced Ambulatory Blood Pressure Monitoring systems. This collaboration has strengthened the company's presence in the national market and improved the quality of diagnostics.
2005
The launch of CardioLight marks a new era in design and technology. Weighing just 47g, the digital Holter recorder is internationally awarded, including the prestigious iF Design Award in Germany, making it one of the most innovative products in the industry.
2010
Cardios launches CardioMapa, a versatile device that allows simultaneous testing of Holter and MAPA. This innovation provides doctors with more agility and convenience, optimizing workflow and diagnostic time.
2019
Cardios expands its line of solutions with the launch of the ARTERIS AOP, an ambulatory monitor for Central Blood Pressure and PWV. The equipment strengthens the company's role in the diagnosis and treatment of hypertension, as well as the assessment of vascular health and aging.
2020
Cardios obtains CE Certification, meeting strict European quality and safety requirements. This achievement expands the company's international reach and reaffirms its commitment to innovation and the reliability of its products.
2021
Cardios launches CardioLight+, bringing its technology to foreign markets, starting with Europe and Asia. This equipment, featuring internal memory, eliminates the need for SD cards, representing the latest breakthrough in practicality and efficiency for Holter monitoring.
2026
Cardioline acquires Cardios, establishing a comprehensive global leadership in cardiac diagnostics. The combination unites Cardioline's international reach and consolidated technology with Cardios's clinical expertise in Holter monitoring and ABPM, strengthening innovation and expanding access to advanced solutions for cardiology.
“Since 1977, Cardios has aimed to build strong and lasting relationships with its clients. Our commitment is to develop reliable and innovative products that combine technological precision and excellent support. Thus, we strive to repay the trust placed in us with solutions that truly make a difference in the care of life.
We believe in the value of dialogue and proximity. Every suggestion, need, or challenge shared by our clients is an opportunity for improvement, allowing our solutions to always be evolving and aligned with market expectations.
This constant partnership drives us to grow alongside doctors, institutions, and patients, strengthening bonds of trust. With innovation and responsibility, we continue to work to transform diagnoses into opportunities to save lives.”
With more than two decades at Cardios, Erica Chriguer has established her career as a benchmark in management and the development of solutions for cardiac diagnosis. A graduate in Health Technology and with a postgraduate degree in Biomedical Engineering, she began her career at the company in 1998, working in different areas until taking over as General Director.
Her leadership is marked by close relationships with clients and partners, a constant pursuit of innovation, and the ability to turn market needs into practical and effective solutions. Over the years, she has helped expand Cardios' presence in different segments and strengthen its reputation as a company of excellence.
Today, at the helm of Cardios, she leads the company through a new cycle of international expansion, now part of the Cardioline group, reinforcing its global presence and commitment to quality, ethics, and innovation.